Optimization of fibrin gelation for enhanced cell seeding and proliferation in regenerative medicine applications

In order to improve the cell seeding efficiency and cell compatibility inside porous tissue scaffolds, a method of fibrin gel‐mediated cell encapsulation inside the scaffold was optimized. Disc‐type poly(d ,l ‐glycolic‐co‐lactic acid) (PLGA) scaffolds without a dense surface skin layer were fabricated using an established solvent casting and particulate leaching method as a model porous scaffold, which showed high porosity ranging from 90 ± 2% to 96 ± 2%. The thrombin and fibrinogen concentration as precursors of fibrin gel was varied to control the gelation kinetics as measured by rheology analysis, and optimized conditions were developed for a uniform fibrin gel formation with the target cells inside the porous PLGA scaffold. The fibroblast cell seeding accompanied by a uniform fibrin gel formation at an optimized gelation condition inside the PLGA scaffold resulted in an increase in cell seeding efficiency, a better cell proliferation, and an increase in final cell density inside the scaffold. Scanning electron microscopy images revealed that cells were better spread and grown by fibrin gel encapsulation inside scaffold compared with the case of bare PLGA scaffold. Copyright © 2016 John Wiley & Sons, Ltd.     

Fabrication of poly(lactide‐co‐glycolide) scaffold embedded spatially with hydroxyapatite particles on pore walls for bone tissue engineering

Poly(lactide‐co‐glycolide) (PLGA) scaffolds embedded spatially with hydroxyapatite (HA) particles on the pore walls (PLGA/HA‐S) were fabricated by using HA‐coated paraffin spheres as porogens, which were prepared by Pickering emulsion. For comparisons, PLGA scaffolds loaded with same amount of HA particles (2%) in the matrix (PLGA/HA‐M) and pure PLGA scaffolds were prepared by using pure paraffin spheres as porogens. Although the three types of scaffolds had same pore size (450–600 µm) and similar porosity (90%–93%), the PLGA/HA‐S showed the highest compression modulus. The embedment of the HA particles on the pore walls endow the PLGA/HA‐S scaffold with a stronger ability of protein adsorption and mineralization as well as a larger mechanical strength against compression. In vitro culture of rat bone marrow stem cells revealed that cell morphology and proliferation ability were similar on all the scaffolds. However, the alkaline phosphatase activity was significantly improved for the cells cultured on the PLGA/HA‐S scaffolds. Therefore, the method for fabricating scaffolds with spatially embedded nanoparticles provides a new way to obtain the bioactive scaffolds for tissue engineering. Copyright © 2011 John Wiley & Sons, Ltd.     

Effect of a scaffold fabricated thermally from acetylated PLGA on the formation of engineered cartilage

A MHDS has been employed to fabricate 3D scaffolds from PLGA with acetyl endgroups to achieve in vivo regeneration of cartilage tissue. The fabricated acetylated-PLGA scaffold showed open pores and interconnected structures. Rabbit chondrocytes were seeded on the PLGA scaffolds and transplanted immediately into subcutaneous sites of athymic mice. Chondrocytes transplantation with untreated PLGA scaffolds served as a control. Histological analysis of the implants at 4 weeks with H&E staining and alcian blue staining revealed higher extracellular matrix and GAG expression at the neocartilage in the PLGA-6Ac scaffolds than that of the PLGA-6OH scaffold group. This endgroup-modified scaffold may be useful for successful cartilage tissue engineering in orthopedic applications.     

Design of a Novel Two‐Component Hybrid Dermal Scaffold for the Treatment of Pressure Sores

The aim of this study is to design a novel two‐component hybrid scaffold using the fibrin/alginate porous hydrogel Smart Matrix combined to a backing layer of plasma polymerized polydimethylsiloxane (Sil) membrane to make the fibrin‐based dermal scaffold more robust for the treatment of the clinically challenging pressure sores. A design criteria are established, according to which the Sil membranes are punched to avoid collection of fluid underneath. Manual peel test shows that native silicone does not attach to the fibrin/alginate component while the plasma polymerized silicone membranes are firmly bound to fibrin/alginate. Structural characterization shows that the fibrin/alginate matrix is intact after the addition of the Sil membrane. By adding a Sil membrane to the original fibrin/alginate scaffold, the resulting two‐component scaffolds have a significantly higher shear or storage modulus G ′. In vitro cell studies show that dermal fibroblasts remain viable, proliferate, and infiltrate the two‐component hybrid scaffolds during the culture period. These results show that the design of a novel two‐component hybrid dermal scaffold is successful according to the proposed design criteria. To the best of the authors' knowledge, this is the first study that reports the combination of a fibrin‐based scaffold with a plasma‐polymerized silicone membrane.     

Functional PLGA Scaffolds for Chondrogenesis of Bone‐Marrow‐Derived Mesenchymal Stem Cells

Two chondrogenic factors, Dex and TGF‐β1, were incorporated into PLGA scaffolds and their chondrogenic potential was evaluated. The Dex‐loaded PLGA scaffold was grafted with AA and heparin, the heparin‐immobilized one was then reacted with TGF‐β1, yielding a PLGA/Dex‐TGF (PLGA/D/T) scaffold. The scaffolds were seeded with rabbit MSCs and cultured for 4 weeks. The results show that the scaffolds including chondrogenic factors strongly upregulated the expression of cartilage‐specific genes and clearly displayed type‐II collagen immunofluorescence. The functionalized PLGA scaffolds could provide an appropriate niche for chondrogenic differentiation of MSC without a constant medium supply of Dex and TGF‐β1.

     

Porous scaffolds based on cross-linking of poly(L-glutamic acid)

Porous scaffolds based on water-soluble PLGA and CS were prepared. The pores were verified to be alveolate, uniform and continuous. The effects of freezing temperature, freeze-drying time, solid content and molecular weight of reactants on the pore structure of the scaffolds were studied. The scaffold morphology could be adjusted by changing the freezing temperature and solid content of reacting polymer. Their degradation rate can be adjusted by changing the proportion of PLGA and CS. The porosity of scaffolds was higher than 90% and the high swelling ratio showed that these scaffolds had excellent hydrophilic performance. The in vitro culture of chondrocytes indicates that the obtained PLGA/CS porous scaffolds are very promising biomaterials for tissue engineering applications.     

Macroporous poly(3-hydroxybutyrate-co-3-hydroxyvalerate) matrices for cartilage tissue engineering

Polymer scaffold systems consisting of poly(hydroxybutyrate-co-hydroxyvalerate) (PHBV) were investigated for possible application as a matrix for the three-dimensional growth of chondrocyte culture. The PHBV scaffolds were fabricated by a compression moulding, thermal processing and salt particulate leaching method without using organic solvent. The porous structure of the scaffolds was investigated with an optical microscope (OM) and scanning electron microscope (SEM) and the porosity was calculated. Then, the chondrocytes were cultured on the PHBV scaffolds for lone time to investigate whether it can be applied to construct the cartilage tissue in vitro. The results showed that the chondrocytes maintained their activity, fully expressed their phenotype and produced the extracellular matrix after incubation in vitro on the scaffolds for 7 days. In addition, in the prolonged incubation time, the percent of chondrocytes in their nature round morphology increased with an increase in the incubation period and they could synthesize the type II collagen and cartilage-specific proteoglycans. All of these results showed that the PHBV scaffolds had the potential to be used as chondrocytes carrier for cartilage engineering.     

Morphological,mechanical, and in vitro cytocompatibility analysis of poly(vinyl alcohol)–silica glass hybrid scaffolds reinforced with cellulose nanocrystals

Cellulose nanocrystal-reinforced poly(vinyl alcohol)/silica glass hybrid scaffolds were fabricated using the freeze-drying method. In this study, we develop molecular-level-based hybrid scaffolds with possible bioactivity behavior by adding silica sol–gel. The results showed a highly porous structure and a significant improvement in mechanical performance (stiffness) of hybrid scaffolds with an increased content of cellulose nanocrystals followed by the addition of silica-based bioactive glass. In vitro cell study with MC3T3-E1 cells on hybrid scaffolds for 1 and 3 days revealed good cell adhesion and growth. Thus, the obtained hybrid scaffold may be a competitive candidate for bone tissue engineering applications.     

Collagen-Derived Biomaterials in Bone and Cartilage Repair

Summary: We have analyzed a number of collagen-derived biomaterials for the matrix- induced and assisted bone and cartilage tissue regeneration. These include the Small intestine submuosa (SIS) Restor ™, ACI-Maix collagen membrane, Chondro- Gide collagen membrane, Permacol collagen Ossix and lycoll collagen membrane and five types of collagen-based marine sponge skeletons. Certain characteristics of different scaffold materials with comparable chemical composition may vary significantly. This variation may have a relevant impact on the suitability of the scaffolds for bone and cartilage regeneration. It suggests that the ACI-Maix® membrane is the best available collagen-derived material for an MACI®/MACT® application. In addition, the study of marine sponge indicates that the collagenous fibre skeleton of marine sponges provides a suitable bioscaffold for bone regeneration, as it supports the adhesion, migration and proliferation of osteoblasts in vitro.     

New cartilage formation in vivo using chondrocytes seeded on poly(L-lactide)

A chondrocyte-poly(L-lactide) (PLLA) composite was employed in an attempt to regenerate cartilage. Rat chondrocytes showed good proliferation on adherent polymer substrates like PLLA and type II collagen production under the in vitro condition. The collagen production became maximal on the 10th day after cultivation. From the in vivo study, seeded chondrocytes spread throughout the scaffold dispersively and a lot of small blood vessels were observed around the matrix when bFGF was coated on the PLLA scaffold. When the chondrocyte-PLLA composite was transplanted into nude mouse, injection of an immunosuppressive agent was not necessary even in an xenograft implantation. A thin layer fibrous capsule was observed surrounding all of the implanted composites, and the inflammatory response of the host to the implants was mild. From the clear histological staining with thionin, it was obvious that the implanted cells exhibited their phenotypes and formed new matured cartilage.     

Cell‐Free HA‐MA/PLGA Scaffolds with Radially Oriented Pores for In Situ Inductive Regeneration of Full Thickness Cartilage Defects

A bioactive scaffold with desired microstructure is of great importance to induce infiltration of somatic and stem cells, and thereby to achieve the in situ inductive tissue regeneration. In this study, a scaffold with oriented pores in the radial direction is prepared by using methacrylated hyaluronic acid (HA‐MA) via controlled directional cooling of a HA‐MA solution, and followed with photo‐crosslinking to stabilize the structure. Poly(lactide‐co‐glycolide) (PLGA) is further infiltrated to enhance the mechanical strength, resulting in a compressive modulus of 120 kPa. In vitro culture of bone marrow stem cells (BMSCs) reveals spontaneous cell aggregation inside this type of scaffold with a spherical morphology. In vivo transplantation of the cell‐free scaffold in rabbit knees for 12 w regenerates simultaneously both cartilage and subchondral bone with a Wakitani score of 2.8. Moreover, the expression of inflammatory factor interleukin‐1β (IL‐1β) is down regulated, although tumor necrosis factor‐α (TNF‐α) is remarkably up regulated. With the anti‐inflammatory, bioactive properties and good restoration of full thickness cartilage defect in vivo, the oriented macroporous HA‐MA/PLGA hybrid scaffold has a great potential for the practical application in the in situ cartilage regeneration.

     

Cell(MC3T3‐E1)‐Printed Poly(ϵ‐caprolactone)/Alginate Hybrid Scaffolds for Tissue Regeneration

A new cell‐printed scaffold consisting of poly(ϵ‐caprolactone) (PCL) and cell‐embedded alginate struts is designed. The PCL and alginate struts are stacked in an interdigitated pattern in successive layers to acquire a three‐dimensional (3D) shape. The hybrid scaffold exhibits a two‐phase structure consisting of cell (MC3T3‐E1)‐laden alginate struts able to support biological activity and PCL struts able to provide controllable mechanical support of the cell‐laden alginate struts. The hybrid scaffolds exhibit an impressive increase in tensile modulus and maximum strength compared to pure alginate scaffolds. Laden cells are homogeneously distributed throughout the alginate struts and the entire scaffold, resulting in cell viability of approximately 84%.     

Preparation and modification of collagen-based porous scaffold for tissue engineering

In the effort to generate cartilage tissues using mesenchymal stem cells, porous scaffolds with prescribed biomechanical properties were prepared. Scaffolds with interconnected pores were prepared via lyophilisation of frozen hydrogels made from collagen modified with chitosan nanofibres, hyaluronic acid, copolymers based on poly(ethylene glycol) (PEG), poly(lactic-co-glycolic acid) (PLGA), and itaconic acid (ITA), and hydroxyapatite nanoparticles. The modified collagen compositions were cross-linked using N-(3-dimethylamino propyl)-N′-ethylcarbodiimide hydrochloride (EDC) combined with N-hydroxysuccinimide (NHS) in water solution. Basic physicochemical and mechanical properties were measured and an attempt to relate these properties to the molecular and supermolecular structure of the modified collagen compositions was carried out. Scaffolds containing hydrophilic chitosan nanofibres showed the highest swelling ratio (SR = 20–25) of all the materials investigated, while collagen modified with an amphiphilic PLGA-PEG-PLGA copolymer or functionalised with ITA exhibited the lowest swelling ratio (SR = 5–8). The best resistance to hydrolytic degradation was obtained for hydroxyapatite containing scaffolds. On the other hand, the fastest degradation rate was observed for synthetic copolymer-containing scaffolds. The results showed that the addition of hydroxyapatite or hyaluronic acid to the collagen matrix increases the rigidity in comparison to the collagen-chitosan scaffold. Collagen scaffold modified with hyaluronic acid presented reduced deformation at break while the presence of hydroxypatatite enhanced the scaffold deformation under tensile loading. The tensile elastic modulus of chitosan nanofibre collagen scaffold was the lowest but closest to the articular cartilage; however, the strength and deformation to failure increased up to 200 %. Presented at the 1st Bratislava Young Polymer Scientists Workshop, Bratislava, 20–23 August 2007.     

Preparation of porous nanocomposite scaffolds with honeycomb monolith structure by one phase solution freezedrying method

Biodegradable porous nanocomposite scaffolds of poly（lactide-co-glycolide）（PLGA） and L-lactic acid（LAc） oligomer surface-grafted hydroxyapatite nanoparticles（op-HA） with a honeycomb monolith structure were fabricated with the single-phase solution freeze-drying method.The effects of different freezing temperatures on the properties of the scaffolds,such as microstructures,compressive strength,cell penetration and cell proliferation were studied.The highly porous and well interconnected scaffolds with a tunable pore structure were obtained.The effect of different freezing temperature（4℃,-20℃,-80℃and -196℃） was investigated in relation to the scaffold morphology,the porosity varied from 91.2%to 83.0%and the average pore diameter varied from（167.2±62.6）μm to（11.9±4.2）μm while theσ₁₀ increased significantly.The cell proliferation were decreased and associated with the above-mentioned properties.Uniform distribution of op-HA particles and homogeneous roughness of pore wall surfaces were found in the 4℃frozen scaffold.The 4℃frozen scaffold exhibited better cell penetration and increased cell proliferation because of its larger pore size,higher porosity and interconnection.The microstructures described here provide a new approach for the design and fabrication of op-HA/PLGA based scaffold materials with potentially broad applicability for replacement of bone defects.     

Controlled release of doxorubicin from electrospun MWCNTs/PLGA hybrid nanofibers

In this study, multiwalled carbon nanotubes (MWCNTs) were used to encapsulate a model anticancer drug, doxorubicin (Dox). Then, the drug-loaded MWCNTs (Dox/MWCNTs) with an optimized drug encapsulation percentage were mixed with poly(lactide-co-glycolide) (PLGA) polymer solution for subsequent electrospinning to form drug-loaded composite nanofibrous mats. The structure, morphology, and mechanical properties of the formed electrospun Dox/PLGA, MWCNTs/PLGA, and Dox/MWCNTs/PLGA composite nanofibrous mats were characterized using scanning electron microscopy (SEM), Fourier transform infrared spectroscopy, and tensile testing. In vitro viability assay and SEM morphology observation of mouse fibroblast cells cultured onto the MWCNTs/PLGA fibrous scaffolds demonstrate that the developed MWCNTs/PLGA composite nanofibers are cytocompatible. The incorporation of Dox-loaded MWCNTs within the PLGA nanofibers is able to improve the mechanical durability and maintain the three-dimensional structure of the nanofibrous mats. More importantly, our results indicate that this double-container drug delivery system (both PLGA polymer and MWCNTs are drug carriers) is beneficial to avoid the burst release of the drug and able to release the antitumor drug Dox in a sustained manner for 42 days. The developed composite electrospun nanofibrous drug delivery system may be used as therapeutic scaffold materials for post-operative local chemotherapy.     

In Vivo Degradation Behavior of Porous Composite Scaffolds of Poly（lactide-co-glycolide） and Nano-hydroxyapatite Surface Grafted with Poly（L-lactide）

The biodegradable porous composite scaffold, composed of poly(lactide-co-glycolide)(PLGA) and hydroxyapatite nanoparticles(n-HAP) surface-grafted with poly(L-lactide)(PLLA)(g-HAP)(g-HAP/PLGA), was fabricated using the solvent casting/particulate leaching method, and its in vivo degradation behavior was investigated by the intramuscular implantation in rabbits. The composite of un-grafted n-HAP/PLGA and neat PLGA were used as controls. The scaffolds had interconnected pore structures with average pore sizes between 137 μm and 148 μm and porosities between 83% and 86%. There was no significant difference in the pore size and porosity among the three scaffolds. Compared with n-HAP/PLGA, the thermo-degradation temperature(Tc) of g-HAP/PLGA decreased while its glass transition temperature(Tg) increased. The weight change, grey value analysis of radiographs and SEM observation showed that the composite scaffolds of g-HAP/PLGA and n-HAP/PLGA showed slower degradation and higher mineralization than the pure PLGA scaffold after the intramuscular implantation. The rapid degradation of PLGA, g-HAP/PLGA and n-HAP/PLGA occurred at 8–12 weeks, 12–16 weeks and 16–20 weeks, respectively. Compared with n-HAP/PLGA, g-HAP/PLGA showed an improved absorption and biomineralization property mostly because of its improved distribution of HAP nanoparticles. The levels of both calcium and phosphorous in serum and urine could be affected to some extent at 3–4 weeks after the implantation of g-HAP/PLGA, but the biochemical detection of serum AST, ALT, ALP, and GGT as well as BUN and CRE showed no obvious influence on the functions of liver and kidney.     

Enhanced mechanical performance and biological evaluation of a PLGA coated β-TCP composite scaffold for load-bearing applications

Porous β-tricalcium phosphate (β-TCP) has been used for bone repair and replacement in clinics due to its excellent biocompatibility, osteoconductivity, and biodegradability. However, the application of β-TCP has been limited by its brittleness. Here, we demonstrated that an interconnected porous β-TCP scaffold infiltrated with a thin layer of poly(lactic-co-glycolic acid) (PLGA) polymer showed improved mechanical performance compared to an uncoated β-TCP scaffold while retaining its excellent interconnectivity and biocompatibility. The infiltration of PLGA significantly increased the compressive strength of β-TCP scaffolds from 2.90 to 4.19 MPa, bending strength from 1.46 to 2.41 MPa, and toughness from 0.17 to 1.44 MPa, while retaining an interconnected porous structure with a porosity of 80.65%. These remarkable improvements in the mechanical properties of PLGA-coated β-TCP scaffolds are due to the combination of the systematic coating of struts, interpenetrating structural characteristics, and crack bridging. The in vitro biological evaluation demonstrated that rat bone marrow stromal cells (rBMSCs) adhered well, proliferated, and expressed alkaline phosphatase (ALP) activity on both the PLGA-coated β-TCP and the β-TCP. These results suggest a new strategy for fabricating interconnected macroporous scaffolds with significantly enhanced mechanical strength for potential load-bearing bone tissue regeneration.     

Poly(l,l-lactide-co-glycolide)/tricalcium phosphate composite scaffold and its various changes during degradation in vitro

A poly(l,l-lactide-co-glycolide) (70/30)/(tricalcium phosphate) (PLGA/TCP) composite scaffold was fabricated by low-temperature deposition (LDM) and its degradation performed in vitro for 22 weeks. Various changes during degradation in vitro, which included changes in acidity of the degradation medium, morphology, weight, composition, molecular weight of the PLGA component and mechanical properties of the scaffold, were investigated. It was found that the acidity of degradation medium of the PLGA(70/30)/TCP composite scaffolds reduced and became much lower than that of TCP-free scaffold. With degradation, the volume and porosity of the PLGA(70/30)/TCP composite scaffold reduced at first then increased slowly, while the surface morphology of the scaffold changed from smooth to rough. The weight loss of the scaffold increased by dissolution of the degraded products and TCP component, but mainly by dissolution of the glycyl-rich degraded products of the PLGA component. The molecular weight of the PLGA component reduced with time, but the molecular weight distribution increased at first and then reduced. The compressive strength and modulus of the scaffold increased at first and then reduced with further degradation. The effect of degradation on modulus was much bigger than that on compressive strength. Based on excellent cell affinity of the PLGA(70/30)/TCP composite scaffold, a potentially useful bone tissue engineering scaffold is proposed.     

Biomimetic hybrid scaffold containing niosomal deferoxamine promotes angiogenesis in full-thickness wounds

Effective management of full-thickness wounds faces significant challenges due to poor angiogenesis and impaired healing. Biomimetic tissue-engineered scaffolds with angiogenic properties can, however, enhance the regeneration capacity of the damaged skin. Here, we developed a hybrid double-layer nanofibrous scaffold, comprised of egg white (EW) and polyvinyl alcohol (PVA), loaded with niosomal Deferoxamine (NDFO) for enhanced angiogenesis and wound healing features. The hybrid scaffold showed enhanced mechanical properties with comparable modulus and shape-recovery behavior of the human skin. Thanks to the porous morphology and uniform distribution of NDFO within the nanofibers, in vitro drug release studies indicated controlled and sustained release of DFO for up to 9 days. The constructs also promoted a significant increase in vascular sprouting area in vitro and enhanced vascular branches ex vivo. In vivo, implantation of the hybrid scaffold in full-thickness wounds in rats revealed early angiogenic response, a higher number of neo-formed vessels, a faster healing rate and complete epithelialization as early as day 10, compared to the control groups. Thus, the presented biomimetic hybrid scaffold with DFO control release features holds great promise in accelerated full-thickness wound healing and soft tissue regeneration.     

Collagen nanofiber-covered porous biodegradable carboxymethyl chitosan microcarriers for tissue engineering cartilage

Nanofibrous collagen-coated porous carboxymethyl chitosan microcarriers (CMC-MCs) were successfully fabricated for use as injectable cell microcarriers. A modified phase separation method combined with temperature controlled freeze-extraction was used for formulating the CMC-MCs. Collagen nanofibers were immobilized onto the surfaces of the CMC-MCs via covalently anchoring some collagen molecules first and more molecules self-assembling into nano-scale fibrous networks afterward. Scanning electron microscopy and hydroxyproline colorimetry analysis revealed that more collagen was immobilized on the CMC-MCs with collagen molecules anchored initially. In vitro cell culture revealed that chondrocytes could adhere, proliferate, and remain differentiated on the nanofiber-coated CMC-MCs. Optical microscopy and confocal laser scanning microscopy showed that chondrocytes grew to confluence on the CMC-MCs within 3 days post-seeding. Subsequently, several confluent CMC-MCs attached to each other, forming tissue-like aggregates after 7 days culture. The mRNA expression of type II collagen was much stronger in chondrocytes cultured on the nanofiber-coated CMC-MCs for 7 days than those cultured in 24-well plates or on CMC-MCs without initial treatment. These porous CMC-MCs could be utilized for cultivating cells and for application in cartilage tissue engineering as injectable scaffolds for cell delivery.